聯(lián)系電話
上海起發(fā)實驗試劑有限公司
中級會員·16年
- 聯(lián)系人：
- 楊經理
- 電話：
- 021-50724187 021-50724961
- 手機：
- 15921799099
- 傳真：
- 021-50724961
- 地址：
- 上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
- 個性化：
- www.qfbio.com
- 網址：
- www.qfbio.com
掃一掃訪問手機商鋪
 提 供 商 |
上海起發(fā)實驗試劑有限公司 |  資料大小 |
12.4KB |
|---|---|---|---|
 資料類型 |
PDF 文件 |  資料圖片 |
|
 下載次數 |
246次 |  瀏覽次數 |
2470次 |
GeneSwith 哺乳動物誘導系統(tǒng)
Invitrogen pGene v5-His
產品參數:
Mammalian Selection：Zeocin
Constitutive/Inducible：Inducible
Expression Level Tightly controlled （activate with mifepristone）
Sequencing Primer pGene Fwd
Sequencing Primer Sequence：5'd[CTGCTATTCTGCTCAACCT]3'
Protein Tags：6X His，V5
載體抗性:
氨芐青霉素（Ampicillin）
載體描述:
Switch-On Expression from the Lowest Basal Levels
The GeneSwitch™ System for inducible mammalian expression is ideal for experiments that require the absolute lowest uninduced expression levels. The expression vector pGene/V5-His provides a minimal promoter, GAL4-E1b, consisting of the binding sites for the yeast Gal4 DNA binding protein followed by the TATA sequence from the Adenovirus E1b promoter. Without additional factors, the GAL4-E1b promoter is transcriptionally silent.
To activate transcription from the GAL4-E1b promoter, the GeneSwitch™ regulatory protein is expressed from a minimal TK promoter on the pSwitch vector. The GeneSwitch™ protein has three functional domains:
- Gal4 DNA Binding Domain （Gal4-DBD） to bind the regulatory protein to the GAL4-E1b promoter
- Truncated human Progesterone Receptor Ligand Binding Domain （hPR-LBD） that undergoes a conformational change when it binds the progesterone antagonist, mifepristone
- Transcription activation domain from the NFØB transcription factor p65 （p6D） to activate transcription from the silent GAL4-E1b promoter
In the absence of mifepristone, the conformation of the hPR-LBD region prevents the GeneSwitch™ regulatory protein from activating transcription from the GAL4-E1b promoter. When mifepristone is added and binds the hPR-LBD region, the GeneSwitch™ regulatory protein assumes a conformation that permits it to stimulate transcription from the GAL4-E1b promoter.
Induction of the GeneSwitch™ System leads to activation of the gene of interest on the vector pGene/V5-His. In addition, four Gal4 binding sites upstream of the minimal HSV TK promoter on pSwitch can bind the pSwitch regulatory protein. Therefore, adding mifepristone up-regulates production of the regulatory protein. The increased levels of the GeneSwitch™ regulatory protein result in induction of the gene of interest from pGene/V5-His to levels that can approach those of viral promoters.
The GeneSwitch™ Kit offers exceptionally low uninduced and high induced expression levels in mammalian cells. The system provides the expression vector pGene/V5-His with the minimal, synthetic GAL4-E1b promoter that is transcriptionally silent until activated. The GeneSwitch™ regulatory protein binds the GAL4-E1b promoter to activate transcription upon the addition of mifepristone. In addition, the GeneSwitch™ protein upregulates its own expression, leading to amplified expression of the gene of interest from pGene/V5-His. pGene/V5-His offers several features that facilitate expression analysis and purification of recombinant proteins in mammalian cells:
- C-terminal V5 epitope tag for detection with Anti-V5 Antibodies
- C-terminal polyhistidine （6xHis） tag for rapid purification with nickel-chelating resin and detection with Anti-His（C-term） Antibodies
- The Zeocin resistance gene for effective selection in both mammalian cells and E. coli
